Institutional Ownership E Ffector Therapeutics, Inc. (EFTR)
This table provides information about the institutional ownership of E Ffector Therapeutics, Inc. (EFTR). We have compiled data on the 6 institutions that hold shares in the stock, with a total of 6.53 Million shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
4,822,114
shares
|
$0
0.69% of portfolio
|
Q3 2021
New holding
|
|
|
Oup Management Co., LLC
|
Nov 09, 2023 Q3 2023 |
1,025,697
shares
|
$0
1.38% of portfolio
|
Q4 2021
New holding
|
|
|
Evolution Capital Management LLC
Crystal Bay, NV |
Feb 13, 2023 Q4 2022 |
527,885
shares
|
$0
1.04% of portfolio
|
Q2 2022
New holding
|
|
|
Parallel Advisors, LLC
|
Aug 08, 2024 Q2 2024 |
67,738
shares
|
$0
0.0% of portfolio
|
Q1 2023
Added 2400.16%
|
|
|
Blackstone Inc
New York, NY |
Aug 14, 2024 Q2 2024 |
52,343
shares
|
$0
0.0% of portfolio
|
Q1 2024
Reduced 96.0%
|
|
|
Resolute Financial, LLC
|
Feb 13, 2023 Q4 2022 |
31,000
shares
|
$0
0.01% of portfolio
|
Q3 2022
Added 3.33%
|